Patents by Inventor Girish Karanth

Girish Karanth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for N-propargylamine derivative
    Patent number: 10842759
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: November 24, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Chandrakant Bamtu Velip, Anup Avijit Choudhury, Girish Karanth, Rajeev Singh Raghuvanshi
  • PHARMACEUTICAL COMPOSITIONS FOR N-PROPARGYLAMINE DERIVATIVE
    Publication number: 20190224143
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: Chandrakant Bamtu VELIP, Anup Avijit CHOUDHURY, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • Pharmaceutical compositions for N-propargylamine derivative
    Patent number: 10292947
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 21, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Chandrakant Bamtu Velip, Anup Avijit Choudhury, Girish Karanth, Rajeev Singh Raghuvanshi
  • NASAL DOSAGE FORMS OF DIHYDROERGOTAMINE
    Publication number: 20190000753
    Abstract: The present application relates to a nasal dosage form of dihydroergotamine, wherein said dosage form requires less than about 15 minutes for administration and requires less than four sprays to administer effective dose of dihydroergotamine for treating migraine in human subjects.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 3, 2019
    Inventors: Aditya NARASIMHA MURTHY, Piyush GUPTA, Arun JANA, Vishal VALLABHADAS RATHI, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • PHARMACEUTICAL COMPOSITIONS FOR N-PROPARGYLAMINE DERIVATIVE
    Publication number: 20170273918
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 28, 2017
    Inventors: Chandrakant Bamtu VELIP, Anup Avijit CHOUDHURY, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
    Publication number: 20080268034
    Abstract: The present invention relates to solid oral dosage forms of ziprasidone and salts thereof and processes for their preparation, containing colloidal silicon dioxide.
    Type: Application
    Filed: January 6, 2006
    Publication date: October 30, 2008
    Inventors: Girish Karanth, Romi Barat Singh, Vishnubhotla Nagaprasad
  • Enteric Coated Didanosine Compositions Having A Subcoat
    Publication number: 20080187561
    Abstract: The present invention relates to enteric coated didanosine compositions having a subcoat comprising hydroxypropyl methylcellulose, and process for preparation thereof. The enteric coating ranges from 19-25% w/w of the composition. The compositions are stable and have acceptable acid resistance and release profile.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 7, 2008
    Inventors: Mona DHALIWAL, Girish Karanth, Romi Barat Singh